(Q41208928)

28 September 2017

title

Mechanisms of inhibition of IL-6-mediated immunoglobulin secretion by dexamethasone and suramin in human lymphoid and myeloma cell lines (English)

1 reference

28 September 2017

1 reference

1 reference

Shiao RT

1

1 reference

28 September 2017

McLeskey SB

2

1 reference

28 September 2017

Khera SY

3

1 reference

28 September 2017

Wolfson A

4

1 reference

28 September 2017

Freter CE

5

1 reference

28 September 2017

publication date

1 April 1996

1 reference

28 September 2017

1 reference

28 September 2017

volume

21

1 reference

28 September 2017

issue

3-4

1 reference

28 September 2017

page(s)

293-303

1 reference

28 September 2017

cites work

B-cell neoplasia in man.

1 reference

https://api.crossref.org/works/10.3109%2F10428199209067610

Interleukin 3 and interleukin 6 synergistically promote the proliferation and differentiation of malignant plasma cell precursors in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209067610

Biological and clinical aspects of interleukin 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209067610

B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209067610

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209067610

Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209067610

Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209067610

IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209067610

Suramin antiviral therapy in the acquired immunodeficiency syndrome. Clinical, immunological, and virologic results

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209067610

Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209067610

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209067610

Bladder cancer. Human leukocyte antigen II, interleukin-6, and interleukin-6 receptor expression determined by the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209067610

Quantitative determination of mRNA phenotypes by the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209067610

Glucocorticoids inhibit the production of IL6 from monocytes, endothelial cells and fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209067610

Cell-specific toxicity of a chimeric protein composed of interleukin-6 and Pseudomonas exotoxin (IL6-PE40) on tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209067610

Suramin is an inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209067610

Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209067610

Dexamethasone and suramin inhibit cell proliferation and interleukin-6-mediated immunoglobulin secretion in human lymphoid and multiple myeloma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209067610

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199209067610

10.3109/10428199209067610

21 January 2018

Identifiers

DOI

1 reference

28 September 2017

1 reference